South American Snake Venoms Affecting Haemostasis

References

• Brazil V. A Defesa Contra o Ophidismo, Pocai & Weiss. Sao Paulo, 1911. Ann. Inst. Pasteur 1928; 42: 403
   Google Scholar
• Stocker K. Inventory of exogenous hemostatic factors affecting the prothrombin activating pathways. Thromb. Haemostas. 1994; 71: 257
   PubMedGoogle Scholar
• Hutton R. A., Warrell D. A. Action of snake venom components on the haemostatic system. Blood Rev. 1993; 7: 176
   PubMed Web of Science ®Google Scholar
• Rosing J., Tans G. Structural and fuctional properties of snake venom prothrombin activators. Toxicon 1992; 30: 1515
   PubMed Web of Science ®Google Scholar
• Rosing J., Tans G. Inventory of exogenous prothrombin activators. Thromb. Haemostas. 1991; 65: 627
   PubMedGoogle Scholar
• Ouyang C., Teng C-M., Huang T-F. Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 1992; 30: 945
   PubMed Web of Science ®Google Scholar
• Ouyang C., Teng C-M., Huang T-F. Characterization of snake venom principles affecting blood coagulation and platelet function. Asia Pacific J. Pharmac 1987; 2: 169
   Google Scholar
• Kamiguti A. S. Enciclopedia Iberoamericana de Hematologia. Editiones Universidad, Salamanca 1992; 667
   Google Scholar
• Smith S. V., Brinkhous K. M. Inventory of exogenous platelet-aggregating agents derived from venoms. Thromb. Haemostas. 1991; 66: 259
   PubMedGoogle Scholar
• Teng C-M., Huang T-F. Inventory of exogenous inhibitors of platelet aggregation. Thromb. Haemostas. 1991; 65: 624
   PubMed Web of Science ®Google Scholar
• Kamiguti A. S., Cardoso J. L. C. Haemostatic changes caused by the venoms of South American snakes. Toxicon 1989; 27: 955
   PubMed Web of Science ®Google Scholar
• Kornalik F. The influence of snake venom enzymes on blood coagulation. Pharmac. Ther. 1985; 29: 353
   PubMedGoogle Scholar
• Tu A. T. Venoms: Chemistry and Molecular Biology. J. Wiley & Sons, New York 1977; 329
   Google Scholar
• von Klobusitzky D., Konig P. Estudos biochimicos sobre os venenos das serpentes do genero Bothrops. III. Separacao do principio anticoagulante dentre a bothropotoxina e outras substancias contidas na secrecao natural. Mem. Inst. Butantan 1935/36; 10: 223
   Google Scholar
• Nahas L., Denson K. W. E., Macfarlane R. G. A study of the coagulant action of eight snake venoms. Thromb. Diath. Haemorrh. 1964; 12: 355
   PubMedGoogle Scholar
• Nahas L., Kamiguti A. S., Barros M. A. R. Thrombin-like and factor X-activator components of Bothrops snake venoms. Thromb. Haemostas. 1979; 41: 314
   PubMed Web of Science ®Google Scholar
• Kirby E. P., Niewiarowski S., Stocker K., Kettner C., Shaw E., Budzynski T. M. Thrombocytin. a serine protease from Bothrops atrox venom. 1. Purification and characterization of the enzyme. Biochemistry 1979; 18: 3564
   PubMed Web of Science ®Google Scholar
• Niewiarowski S., Kirby E. P., Budzynski T. M., Stocker K. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors. Biochemistry 1979; 18: 3570
   PubMed Web of Science ®Google Scholar
• Hill-Eubanks D. C., Parker C. G., Lollar P. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin. Proc. Natl. Acad. Sci. USA 1989; 86: 6508
   PubMedGoogle Scholar
• Nishida S., Fujimura Y., Miura S., Ozaki Y., Usami Y., Suzuki M., Titani K., Yoshida E., Sugimoto M., Yoshioka A., Fukui H. Purification and characterization of bothrombin, a fibrinogen-clotting serine protease from the venom of Bothrops jararaca. Biochemistry 1994; 33: 1843
   PubMed Web of Science ®Google Scholar
• Rosenfeld G., Kelen E. M. A., Nahas L. Coagulant and fibrinolytic activity of animal venoms; determination of coagulant and fibrinolytic index of different species. Mem. Inst. Butantan 1959; 29: 143
   PubMedGoogle Scholar
• Furtado M. F. D., Maruyama M., Kamiguti A. S., Antonio L. C. Comparative study of nine Bothrops snake venoms from adult female snakes and their offspring. Toxicon 1991; 29: 219
   PubMed Web of Science ®Google Scholar
• Meier J. Individual and age-dependent variation in the venom of the fer-de-lance (Bothrops atrox). Toxicon 1986; 24: 41
   PubMed Web of Science ®Google Scholar
• Theakston R. D. G., Reid H. A. Changes in the biological properties of venom from Crotalus atrox with ageing. Period. Biol. 1978; 80: 123
   Web of Science ®Google Scholar
• Kamiguti A. S., Antonio L. C., Mariano M. Progress in Venom and Toxin Research, P. Gopalakrishnakone, C. K. Tan. National University of Singapore, Singapore 1987; 296
   Google Scholar
• Santoro M. L., Sano-Martins I. S. Different clotting mechanisms of Bothrops jararaca snake venom on human and rabbit plasmas. Toxicon 1993; 31: 733
   PubMedGoogle Scholar
• Hessel B., Blomback B. The proteolytic actions of the snake venom enzymes arvin and reptilase on N-terminal chain fragment of human fibrinogen. FEBS Lett. 1971; 18: 318
   PubMedGoogle Scholar
• Blomback B., Vestermark A. Isolation of fibrinopeptides by chromatography. Arkiv Kemi 1958; 12: 173
   Google Scholar
• Kudryk B., Collen D., Woods K. R., Blomback B. Evidence for localization of polymerization sites in fibrinogen. J. Biol. Chem. 1974; 249: 3322
   PubMedGoogle Scholar
• Olexa S. A., Budzynski A. Z. Evidence for four different polymerization sites involved in fibrin formation. Proc. Natl. Acad. Sci. USA 1980; 77: 1374
   PubMedGoogle Scholar
• Blomback B., Hessel B., Hogg D., Therkildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature 1978; 275: 501
   PubMed Web of Science ®Google Scholar
• Holleman W. H., Weiss L. J. The thrombin-like enzyme from Bothrops atrox snake venom. J. Biol. Chem. 1976; 251: 1663
   PubMed Web of Science ®Google Scholar
• Stocker K., Barlow G. H. The coagulant enzyme from Bothrops atrox venom (Batroxobin). Meth. Enzym. 1976; 45: 214
   PubMedGoogle Scholar
• Selistre H. S., Giglio J. R. Isolation and characterization of a thrombin-like enzyme from the venom of the snake Bothrops insularis (Jararaca ilhoa). Toxicon 1987; 25: 1135
   PubMed Web of Science ®Google Scholar
• Aragon-Ortiz F., Gubensek F. Bothrops asper venom from the Atlantic and Pacific zones of Costa Rica. Toxicon 1981; 19: 797
   PubMedGoogle Scholar
• Raw I., Rocha M. C., Esteves M. I., Kamiguti A. S. Isolation and characterization of a thrombin-like enzyme from the venom of Crotalus durissus terrificus. Braz. J. med. Biol. Res. 1986; 19: 333
   PubMedGoogle Scholar
• Alexander G., Grothusen J., Zepeda H., Schwartzman R. J. Gyroxin, a toxin from the venom of Crotalus durissus terrificus, is a thrombin-like enzyme. Toxicon 1988; 26: 953
   PubMed Web of Science ®Google Scholar
• Magalhaes A., Sousa A. J., Diniz C. R. Proteases de serpentes brasileiras, I, Separacao da enzima coagulante clotase do veneno de Lachesis muta. Ciencia e Cultura 1973; 25: 873
   Google Scholar
• Yarleque A., Campos S., Escobar E., Lazo F., Sanchez N., Hyslop S., Marsh N. A., Butterworth P. J., Price R. G. Isolation and characterization of a fibrinogen-clotting enzyme from the venom of the Peruvian bushmaster. Lachesis muta muta. Toxicon 1989; 27: 1189
   PubMedGoogle Scholar
• Orejuela P., Zavaleta A., Salas M., Marsh N. A. Thrombin-like activity in snake venoms from Peruvian BothropsLachesis genera. Toxicon 1991; 29: 1151
   PubMedGoogle Scholar
• Magalhaes A., Oliveira G., Diniz C. R. Purification and partial characterization of a thrombin-like enzyme from the venom of the bushmaster snake Lachesis muta noctivaga. Toxicon 1981; 19: 279
   PubMedGoogle Scholar
• Stocker K., Fisher H., Meier J. Thrombin-like snake venom proteases. Toxicon 1982; 20: 265
   PubMed Web of Science ®Google Scholar
• Denson K. W. E., Russell F. E., Almagro D., Bishop R C. Characterization of the coagulant activity of some snake venoms. Toxicon 1972; 10: 557
   PubMed Web of Science ®Google Scholar
• Kornalik F., Blomback B. Prothrombin activation induced by ecarin, a prothrombin-converting enzyme from Echis carinatus venom. Thromb. Res. 1975; 6: 53
   Google Scholar
• Novoa E., Seegers W. H. Mechanism of α-thrombin and β-thrombin-E formation: use of ecarin for isolation of meizothrombin I. Thromb. Res. 1980; 18: 657
   PubMedGoogle Scholar
• Hofmann H., Bon C. Blood coagulation induced by the venom of Bothrops atrox. 1. Identification, purification and properties of a prothrombin activator. Biochemistry 1987; 26: 772
   PubMed Web of Science ®Google Scholar
• Govers-Riemslag J. W. P., Knapen M. J. H., Tans G., Zwaal R. F. A., Rosing J. Structural and functional characterization of a prothrombin activator from the venom of Bothrops neuwiedi. Biochim. Biophys. Acta 1987; 916: 388
   PubMedGoogle Scholar
• Maruyama M., Kamiguti A. S., Tomy S. C., Antonio L. C., Sugiki M., Mihara H. Prothrombin and factor X-activating properties of Bothrops erythromelas venom. Ann. trop. Med. Parasitol. 1992; 86: 549
   PubMed Web of Science ®Google Scholar
• Hofmann H., Bon C. Blood coagulation induced by the venom of Bothrops atrox. 2. Identification, purification and properties of two Factor X activators. Biochemistry 1987; 26: 780
   PubMed Web of Science ®Google Scholar
• Denson K. W. E., Rousseau W. E. Separation of the coagulant components of Bothrops jararaca venom. Toxicon 1970; 8: 15
   PubMed Web of Science ®Google Scholar
• Furukawa Y., Hayashi K. Factor X-converting and thrombin-like activities of Bothrops jararaca venom. Toxicon 1977; 23: 107
   Google Scholar
• Boffa M. C., Boffa G. A. A phospholipase A2 with anticoagulant activity II Inhibition of the phospholipid activity in coagulation. Biochim. Biophys. Acta 1976; 429: 839
   PubMedGoogle Scholar
• Kini R. M., Evans H. J. Structure-function relationships of phospholipases. J. Biol. Chem. 1987; 262: 14402
   PubMedGoogle Scholar
• Verheij H. M., Slotboom A. J., De Haas G. H. Structure and function of phospholipase A2. Rev. Physiol. Biochem. Pharmac. 1981; 91: 91
   PubMed Web of Science ®Google Scholar
• Rosenberg P. Pharmacology of phospholipase A2 from snake venoms. Hand. Exp. Pharmacol. 1979; 52: 403
   Google Scholar
• Frankel-Conrat H. Snake venom neurotoxins related to phospholipase A2. J. Toxic.-Toxin Rev. 1982/83; 1: 205
   Google Scholar
• Gopalakrishnakone P., Dempster D. W., Hawgood B. J., Elder H. Y. Cellular and mitochondrial changes induced in the structure of murine muscle by crotoxin, a neurotoxic phospholipase A2 complex. Toxicon 1984; 22: 85
   PubMedGoogle Scholar
• Kamiguti A. S., Sousae Silva M. C., Morena P., Nahas L. The anticoagulant effect of Bothrops castelnaudi snake venom (Castelnaud's pit viper). Toxicon 1985; 23: 383
   PubMedGoogle Scholar
• Zingali R. B., Jandrot-Perrus M., Guillin M. C., Bon C. Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom; characterization and mechanism of thrombin inhibition. Biochemistry 1993; 32: 10794
   PubMedGoogle Scholar
• Sekiya F., Atoda H., Morita T. Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca. Biochemistry 1993; 32: 6892
   PubMedGoogle Scholar
• Niewiarowski S., Kirby E. P., Stocker K. Thrombocytin: a novel platelet activating enzyme from Bothrops atrox venom. Thromb. Res. 1977; 10: 863
   PubMedGoogle Scholar
• Kubisz P., Arabi A., Seghier F., Cronberg S. Investigations on the effect of thrombocytin on platelets. Thromb. Res. 1984; 33: 225
   PubMedGoogle Scholar
• Teng C-M., Ko F. N. Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin. Thromb. Haemostas. 1988; 59: 304
   PubMedGoogle Scholar
• Zingali R. B., Carlini C. R., Francischetti I. M., Guimaraes J. A. Bothrops jararaca venom: effects on platelet aggregation. Thromb. Res. 1990; 58: 303
   PubMedGoogle Scholar
• Serrano S. M. T., Matos M. F. C., Mandelbaum F. R., Sampaio C. A. M. Basic proteinases from Bothrops moojeni (caissaca) venom I Isolation and activity of two serine proteinases, MSP1 and MSP2, on synthetic substrates and on platelet aggregation. Toxicon 1993; 31: 471
   PubMedGoogle Scholar
• Gartner T. K., Stocker K., Williams D. C. Thrombolectin: a lectin isolated from Bothrops atrox venom. FEBS Lett. 1980; 117: 13
   PubMedGoogle Scholar
• Ogilvie M. L., Byl J. W., Gartner T. K. Platelet aggregation is stimulated by lactose-inhibitable snake venom lectins. Thromb. Haemostas. 1989; 62: 704
   PubMedGoogle Scholar
• Ogilvie M. L., Docker M. E., Wenz L., Gartner T. K. Isolation and characterization of lactose-inhibitable lectins from the venoms of the snakes Lachesis mutaDendroaspis jamesonii. J. Biochem. 1986; 100: 1425
   PubMedGoogle Scholar
• Gartner T. K., Ogilvie M. L. Isolation and characterization of three Ca2+-dependent β-galactoside-specific lectins from snake venoms. Biochem. J. 1984; 224: 301
   PubMedGoogle Scholar
• Ozeki Y., Matsui T., Hamako J., Suzuki M., Fujimura Y., Yoshida E., Nishida S., Titani K. C-type galactoside-binding lectin from Bothrops jararaca venom: comparison of its structure and function with those of botrocetin. Arch. Biochem. Biophys 1994; 308: 306
   PubMedGoogle Scholar
• Prado-Franceschi J., Vital Brazil O. Convulxin, a new toxin from the venom of the South American rattlesnake Crotalus durissus terrificus. Toxicon 1981; 19: 875
   PubMed Web of Science ®Google Scholar
• Marlas G., Joseph D., Huet C. Subunit structure of a potent platelet-aggregating glycoprotein from the venom of Crotalus durissus cascavella. Biochemie 1983; 65: 619
   PubMed Web of Science ®Google Scholar
• Vargaftig B. B., Prado-Franceschi J., Chignard M., Lefort J., Marlas G. Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavella. Eur. J. Pharmacol. 1980; 68: 451
   PubMed Web of Science ®Google Scholar
• Marlas G. Isolation and characterization of the alpha and beta subunits of the platelet-activating glycoprotein from the venom of Crotalus durissus cascavella. Biochemie 1985; 67: 1231
   PubMedGoogle Scholar
• Sano-Martins I. S., Daimon T. Electron microscopic cytochemistry on the distribution of wheat germ agglutinin receptor on the platelet plasma membrane after treatment with convulxin isolated from Crotalus durissus terrificus venom. Toxicon 1992; 30: 141
   PubMedGoogle Scholar
• Vargaftig B. B., Joseph D., Wal F., Marlas G., Chignard M., Chevance L. G. Convulxin-induced activation of intact and of degranulated rabbit platelets: specific crossed desensitisation with collagen. Eur. J. Pharmacol. 1983; 92: 57
   PubMed Web of Science ®Google Scholar
• Faili A., Randon J., Francischetti I. M. B., Vargaftig B. B., Hatmi M. Convulxin-induced platelet aggregation is accompanied by a powerful activation of the phospholipase C pathway. Biochem. J. 1994; 298: 87
   PubMed Web of Science ®Google Scholar
• Billah M M., Lapetina E. G. Rapid decrease of phosphatidylinositol 4,5-biphosphate in thrombin-stimulated platelets. J. Biol. Chem. 1982; 257: 12705
   PubMed Web of Science ®Google Scholar
• Morrison W. J., Shukla S. D. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets. J. Pharmacol. Exp. Ther. 1989; 250: 831
   PubMedGoogle Scholar
• Read M. S., Shermer R. W., Brinkhous K. M. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc. Natl. Acad. Sci. USA 1978; 75: 4514
   PubMed Web of Science ®Google Scholar
• Read M. S., Smith S. V., Lamb M. A., Brinkhous K. M. Role of botrocetin in platelet agglutination: Formation of an activated complex of botrocetin and von Willebrand factor. Blood 1989; 74: 1031
   PubMedGoogle Scholar
• Fujimura Y., Holland L. Z., Ruggeri Z. M., Zimmerman T. S. The von Willebrand factor domain-mediating botrocetin-induced binding to glycoprotein Ib lies between Val449 and Lys728. Blood 1985; 70: 985
   Google Scholar
• Sugimoto M., Mohri H., McClintock R. A., Ruggeri Z. M. Identification of discontinous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J. Biol. Chem. 1991; 266: 18172
   PubMedGoogle Scholar
• Andrews R. K., Booth W. J., Gorman J. J., Castaldi P. A., Berndt M. C. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1989; 28: 8317
   PubMedGoogle Scholar
• Andrews R. K., Gorman J. J., Booth W. J., Corino G. L., Castaldi P. A., Berndt M. C. Cross-linking of a monomeric 39/34 kDa dispase fragment of von Willebrand factor (Leu480/Val481 - Gly718) to the N-terminal region of the alpha chain of membrane glycoprotein Ib on intact platelets with bis-(sulfosuccinimidyl)suberate. Biochemistry 1989; 28: 8326
   PubMedGoogle Scholar
• Bahnak B. R., Lavergne J. M., Ferreira V., Kerbiriou-Nabias D., Meyer D. Comparison of the primary structure of the functional domains of human and porcine von Willebrand factor that mediate platelet adhesion. Biochem. Biophys. Res. Commun. 1992; 182: 561
   PubMed Web of Science ®Google Scholar
• Berndt M. C., Booth W. J., Andrews R. K., Castaldi P. A. Definition of von Willebrand factor (vWF)-gpIb/IX complex interaction using vWF-based peptides. Thromb. Haemostas. 1991; 65: 748
   Google Scholar
• Fujimura Y., Titani K., Usami Y., Suzuki M., Oyama R., Matsui T., Fukui H., Sugimoto M., Ruggeri Z. M. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 1991; 30: 1957
   PubMedGoogle Scholar
• Fujimura Y., Usami Y., Titani K., Niinomi K., Nishio K., Takase T., Yoshika A., Fukui H. Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib. Blood 1991; 77: 113
   PubMedGoogle Scholar
• Rabinowitz I., Tuley E. A., Mancuso D. J., Randi A. M., Firkin B. G., Howard M. A., Sadler J. E. von Willebrand disease type B: a missence mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib. Proc. Natl. Acad. Sci. USA 1992; 89: 9846
   PubMed Web of Science ®Google Scholar
• Brinkhous K. M., Read M. S., Fricke W. A., Wagner R. H. Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc. Natl. Acad. Sci. USA 1983; 80: 1463
   PubMed Web of Science ®Google Scholar
• Brinkhous K. M., Barnes D. S., Potter J. Y., Read M. S. von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutinin. Proc. Natl. Acad. Sci. USA 1981; 78: 3230
   PubMedGoogle Scholar
• Usami Y., Fujimura Y., Suzuki M., Ozeki Y., Fukui H., Titani K. Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca. Proc. Natl. Acad. Sci. USA 1993; 90: 928
   PubMedGoogle Scholar
• Huang T-F., Holt J. C., Lukasiewicz H., Niewiarowski S. Trigramina low molecular weight peptide inhibiting fibrinogen interaction with receptors expressed on glycoprotein IIb/IIIa complex. J. Biol. Chem. 1987; 262: 16157
   PubMed Web of Science ®Google Scholar
• Huang T-F., Holt E. P., Kirby E. P., Niewiarowski S. Trigramin: primary structure and its inhibition on von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Biochemistry 1989; 28: 661
   PubMed Web of Science ®Google Scholar
• Ruoslahti E., Pierschbacher M. D. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491
   PubMed Web of Science ®Google Scholar
• Rucinski B., Niewiarowski S., Holt J. C., Soszka T., Knudsen K. A. Batroxostatin, an Arg-Gly-Asp-containing peptide from Bothrops atrox, is a potent inhibitor of platelet aggregation and cell interaction with fibronectin. Biochim. Biophys. Acta 1990; 1054: 257
   PubMedGoogle Scholar
• Scarborough R. M., Rose J. W., Naughton M. A., Phillips D. R., Nannizzi L., Arfsten A., Campbell A. M., Charo I. F. Characterization of the integrin specificities of disintegrins isolated from American pit vipers venoms. J. Biol. Chem. 1993; 268: 1058
   PubMed Web of Science ®Google Scholar
• Mebs D. A comparative study of enzyme activity in snake venoms. Int. J. Biochem. 1970; 1: 335
   Google Scholar
• Tan N. H., Ponnudurai G. A comparative study of the biological properties of some venoms of snakes of the genus Bothrops (American lance-headed viper). Comp. Biochem. Physiol. 1991; 100B: 361
   Google Scholar
• Machado O. L. T., Oliveira-Carvalho A. L., Zingali R. B., Carlini C. Purification, physicochemical characterization and N-terminal amino acid sequence of a phospholipase A2 from Bothrops jararaca venom. Braz. J. Med. Biol. Res. 1993; 26: 163
   PubMedGoogle Scholar
• Kini R. M., Evans H. J. Correlation between the enzymatic activity, anticoagulant and antiplatelet effects of phospholipase A2 isoenzymes from Naja nigricollis venom. Thromb. Haemostas. 1988; 60: 170
   PubMed Web of Science ®Google Scholar
• Teng C-M., Chen Y. H., Ouyang C. Biphasic effect on platelet aggregation by phospholipase A purified from Vipera russellii snake venom. Biochim. Biophys. Acta 1984; 772: 393
   PubMedGoogle Scholar
• Huang T-F., Yeh H. I., Ouyang C. Mechanism of action of the platelet aggregation inhibitor purified from Agkistrodon halys (mamushi) snake venom. Toxicon 1984; 22: 243
   PubMed Web of Science ®Google Scholar
• Yuan Y., Jackson S. P., Mitchell C. A., Salem H. H. Purification and characterization of a snake venom phospholipase A2: a potent inhibitor of platelet aggregation. Thromb. Res. 1993; 70: 471
   PubMed Web of Science ®Google Scholar
• Rosenfeld G. Symptomatology, pathology and treatment of snake bites. Venomous Animals and Their Venoms South America, W. Bucherl, E. Buckley, V. Deulofeu. Academic Press, New York 1971; 345
   Google Scholar
• World Health Organization. Progress in the characterization of venoms and standardization of antivenoms. Geneve 1981; 44, WHO Offset Publicationn. 58
   Google Scholar
• Haad J. S. Accidentes humanos por las serpientes de los generos Bothrops y Lachesis. Mem. Inst. Butantan 1980/81; 44/45: 403
   Google Scholar
• Bolanos R., Rojas O., Flores C. E. U. Aspectos biomedicos de cuatro casos de mordedura de serpiente por Lachesis muta (Ophidia: Viperidae) en Costa Rica. Rev. Biol. trop. 1982; 30: 53
   PubMedGoogle Scholar
• Maruyama M., Kamiguti A. S., Cardoso J. L. C., Sano-Martins I. S., Chudzinski A. M., Santoro M. L., Morena P., Tomy S. C., Antonio L. C., Mihara H., Kelen E. M. A. Studies on blood coagulation and fibrinolysis in patients bitten by Bothrops jararaca (jararaca). Thromb. Haemostas. 1990; 63: 449
   PubMed Web of Science ®Google Scholar
• Cardoso J. L. C., Fan H. W., Franca F. O. S., Jorge M. T., Leite R. P., Nishioka S. A., Avila A., Sano-Martins I. S., Tomy S. C., Santoro M. L., Chudzinski A. M., Castro S. C. B., Kamiguti A. S., Kelen E. M. A., Hirata M. H., Mirandola R. M. S., Theakston R. D. G., Warrell D. A. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in Sao Paulo, Brazil. Q. J. Med. 1993; 86: 315
   PubMedGoogle Scholar
• Kamiguti A. S., Cardoso J. L. C., Theakston R. D. G., Sano-Martins I. S., Rugman F. P., Warrell D. A., Hay C. R. M. Coagulopathy and haemorrhage in human victims of Bothrops jararaca envenoming in Brazil. Toxicon 1991; 29: 961
   PubMed Web of Science ®Google Scholar
• Kamiguti A. S., Rugman F. P., Theakston R. D. G., Franca F. O. S., Ishii H., Hay Biasg C. R. M. The role of venom haemorrhagin in spontaneous bleeding in Bothrops jararaca envenoming. Thromb. Haemostas. 1992; 67: 484
   PubMed Web of Science ®Google Scholar
• Kamiguti A. S., Matsunaga S., Spir M., Sano-Martins I. S., Nahas L. Alteration of the blood coagulation system after accidental human inoculation by Bothrops jararaca venom. Braz. J. Med. Biol. Res. 1986; 19: 199
   PubMed Web of Science ®Google Scholar
• Rosenfeld G., Kelen E. M. A., Nahas L. Regeneration of fibrinogen after defibrination by bothropic venom in man and dogs. Relationships with clotting and bleeding time. Rev. clin. Sao Paulo 1958; 34: 36
   Google Scholar
• Dempfle C. E., Kohl R., Harenberg J., Kirschtein W., Schlauch D., Haene D. L. Coagulopathy after snake bite by Bothrops neuwiedi: a case report and result of in vitro experiments. Blut 1990; 61: 369
   PubMedGoogle Scholar
• Estrade G., Garnier D., Bemasconi F., Donatien Y. Pulmonary embolism and disseminated intravascular coagulation after being bitten by a Bothrops lanceolatus snake A propos of a case. Arch. Mal. Coeur Vaiss. 1989; 82: 1903
   PubMedGoogle Scholar
• Amaral C. F., Rezende N. A., Pedrosa T. M., da Silva O. A., Pedroso E. R. Afibrinogenemia secondary to crotalid bite (Crotalus durissus terrificus). Rev. Inst. Med. Trop. Sao Paulo 1988; 30: 288
   PubMedGoogle Scholar
• Amaral C. F. S., da Silva O. A., Lopes M., Pedroso E. R. P. Afibrinogenemia following snake bite (Crotalus durissus terrificus). Amer. J. trop. Med. Hyg. 1980; 29: 1453
   PubMedGoogle Scholar
• Thomazini I A., Iuan F. C., Carvalho I., Hermandes D. H., Amaral I. F., Pereira P. C. M., Barravieira B. Evaluation of platelet function and serum fibrinogen level in patients bitten by snakes of the genus Crotalus. Preliminary report. Rev. Inst. Med. Trop. Sao Paulo 1991; 33: 219
   PubMedGoogle Scholar